Artgen Biotech PJSC (MOEX:ISKJ)
Russia
· Delayed Price · Currency is RUB 59.54
+0.84 (1.43%)
At close: Jul 8, 2022
Artgen Biotech PJSC Ratios and Metrics
Market cap in millions RUB. Fiscal year is January - December.
Millions RUB. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jul '22 Jul 7, 2022 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 4,287 | 4,401 | 4,419 | 4,287 | 8,272 | 2,747 | Upgrade
|
| Market Cap Growth | - | -0.41% | 3.10% | -48.18% | 201.10% | 193.76% | Upgrade
|
| Enterprise Value | 4,936 | 5,317 | 5,296 | 5,060 | 8,928 | 3,367 | Upgrade
|
| Last Close Price | 59.54 | 59.54 | 59.54 | 59.54 | 114.90 | 38.16 | Upgrade
|
| PE Ratio | 22.41 | 20.48 | 26.17 | 92.95 | 711.21 | 37.71 | Upgrade
|
| PS Ratio | 2.65 | 2.89 | 3.23 | 3.77 | 7.01 | 2.53 | Upgrade
|
| PB Ratio | 3.49 | 4.10 | 4.53 | 7.52 | 17.96 | 6.62 | Upgrade
|
| P/TBV Ratio | 21.17 | 74.03 | 17.75 | 22.45 | 77.90 | 35.53 | Upgrade
|
| P/FCF Ratio | 13.81 | 11.52 | 19.17 | 50.80 | 64.88 | - | Upgrade
|
| P/OCF Ratio | 11.19 | 9.13 | 10.16 | 19.46 | 29.46 | 51.01 | Upgrade
|
| EV/Sales Ratio | 3.06 | 3.50 | 3.87 | 4.45 | 7.56 | 3.11 | Upgrade
|
| EV/EBITDA Ratio | 14.19 | 15.00 | 16.32 | 36.80 | 47.29 | 13.42 | Upgrade
|
| EV/EBIT Ratio | 20.73 | 17.75 | 19.23 | 51.92 | 68.45 | 17.01 | Upgrade
|
| EV/FCF Ratio | 15.90 | 13.91 | 22.97 | 59.97 | 70.02 | - | Upgrade
|
| Debt / Equity Ratio | 0.56 | 0.69 | 0.81 | 1.46 | 1.34 | 1.18 | Upgrade
|
| Debt / EBITDA Ratio | 1.90 | 1.92 | 2.27 | 5.51 | 2.94 | 1.81 | Upgrade
|
| Debt / FCF Ratio | 2.21 | 1.93 | 3.41 | 9.86 | 4.84 | - | Upgrade
|
| Asset Turnover | 0.61 | 0.58 | 0.60 | 0.60 | 0.73 | 0.75 | Upgrade
|
| Inventory Turnover | 2.00 | 1.86 | 1.75 | 1.99 | 1.93 | 1.91 | Upgrade
|
| Quick Ratio | 1.59 | 1.40 | 1.30 | 0.90 | 0.81 | 0.43 | Upgrade
|
| Current Ratio | 2.79 | 2.29 | 1.99 | 1.74 | 1.77 | 1.04 | Upgrade
|
| Return on Equity (ROE) | 24.73% | 23.55% | 25.20% | 4.48% | 7.66% | 26.32% | Upgrade
|
| Return on Assets (ROA) | 5.98% | 7.18% | 7.50% | 3.22% | 5.02% | 8.50% | Upgrade
|
| Return on Capital (ROIC) | 8.59% | 10.48% | 10.88% | 4.91% | 8.23% | 14.57% | Upgrade
|
| Return on Capital Employed (ROCE) | 10.60% | 13.60% | 13.90% | 5.90% | 9.60% | 20.70% | Upgrade
|
| Earnings Yield | 5.76% | 4.88% | 3.82% | 1.08% | 0.14% | 2.65% | Upgrade
|
| FCF Yield | 7.24% | 8.68% | 5.22% | 1.97% | 1.54% | -1.16% | Upgrade
|
| Dividend Yield | - | - | 2.02% | 1.68% | - | - | Upgrade
|
| Payout Ratio | 56.98% | 65.46% | 61.72% | - | - | - | Upgrade
|
| Buyback Yield / Dilution | -25.66% | - | -6.60% | -8.64% | -6.67% | - | Upgrade
|
| Total Shareholder Return | -25.66% | - | -4.58% | -6.96% | -6.67% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.